Purpose To update the American Society of Clinical Oncology (ASCO)/College of American
Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor …

Purpose.—To develop a guideline to improve the accuracy of immunohistochemical (IHC)
estrogen receptor (ER) and progesterone receptor (PgR) testing in breast cancer and the …

Purpose To develop a guideline to improve the accuracy of human epidermal growth factor
receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker. …

… The Panel also recommends that surgeons (a) take a formal course on the technique,
with didactic and hands-on training components; (b) have an experienced mentor; (c) keep …

Purpose.— To update key recommendations of the American Society of Clinical Oncology (ASCO)/College
of American Pathologists (CAP) human epidermal growth factor receptor 2 (…

Purpose Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (…

Purpose To update the 2003 American Society of Clinical Oncology technology assessment
on adjuvant use of aromatase inhibitors. Recommendations Based on results from multiple …

Background We compared the efficacy of two different taxanes, docetaxel and paclitaxel,
given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer. Methods We …

Context Diabetes mellitus appears to be a risk factor for some cancers, but the effect of
preexisting diabetes on all-cause mortality in newly diagnosed cancer patients is less clear. …

Purpose: To update key recommendations of the American Society of Clinical Oncology/College
of American Pathologists estrogen (ER) and progesterone receptor (PgR) testing in …